Trial intelligence / Profile preview

Vitamin A Supplementation in Newborns Study

NCT00114868Phase 3Completed

Sponsor
Johns Hopkins Bloomberg School of Public Health
Start
Jun 1998
Primary completion
Apr 2001
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Vitamin A deficiency (VAD) comparing Vitamin A with Placebo (2 arms). Primary endpoint: Infant Mortality at 6 months. Started Jun 1998; status: completed.

02

Drugs

vitamin a
03

Conditions

Vitamin A deficiency (VAD)

Beyond the preview

Go deeper on NCT00114868.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00114868.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call